Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1996 Apr;49(4):278–283. doi: 10.1136/jcp.49.4.278

Lipid screening in an elderly population: difficulty in interpretation and in detection of occult metabolic disease.

A F Winder 1, C Jagger 1, D P Garrick 1, D T Vallance 1, P F Butowski 1, J Anderson 1, M Clarke 1
PMCID: PMC500446  PMID: 8655701

Abstract

AIMS: To determine lipid profiles and associations with other metabolic disease in a representative British elderly population. METHODS: Part of a prevalence survey of dementia in all 75+ year olds conducted from the large general practice serving the town and surrounding area of Melton Mowbray, Leicestershire (the M-old study). Patients (n = 224) aged from 75 to 98 years, and representative of the overall population, also provided pre-prandial blood samples on which various age and nutrition related analytes were determined. These included documented medical history, thyroid stimulating hormone (TSH), glucose, immunoglobulins, and lipid profile in plasma. RESULTS: Cholesterol and lipid variables showed wide scatter, with some negative trends but no significant associations with age for total cholesterol, high density lipoprotein (HDL) cholesterol, the ratio of total to HDL cholesterol or triglycerides. Women had significantly higher concentrations of total and HDL cholesterol at all ages. Serum TSH was above 6.0 mU/1 in 10/205 patients, random glucose was above 11.2 mmol/l in nine of 207 patients, borderline dysglobulinaemia was present in four of 210 patients, all without correlation with cholesterol concentrations. CONCLUSION: This British data is consistent with an inverse correlation between survival and cholesterol, but wide scatter restricts reliance on single result lipid data in individual patient management. Random lipid screening is also unhelpful, inefficient and without added value in revealing other age related and unrecognised occult metabolic disease.

Full text

PDF
278

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. M., Castelli W. P., Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA. 1987 Apr 24;257(16):2176–2180. doi: 10.1001/jama.257.16.2176. [DOI] [PubMed] [Google Scholar]
  2. Aviram M., Luboshitzky R., Brook J. G. Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy. Clin Biochem. 1982 Feb;15(1):62–66. doi: 10.1016/s0009-9120(82)90529-x. [DOI] [PubMed] [Google Scholar]
  3. Ball M. J., Griffiths D., Thorogood M. Asymptomatic hypothyroidism and hypercholesterolaemia. J R Soc Med. 1991 Sep;84(9):527–529. doi: 10.1177/014107689108400908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barrett-Connor E., Criqui M. H., Witztum J. L., Philippi T., Zettner A. Population-based study of glycosylated hemoglobin, lipids, and lipoproteins in nondiabetic adults. Arteriosclerosis. 1987 Jan-Feb;7(1):66–70. doi: 10.1161/01.atv.7.1.66. [DOI] [PubMed] [Google Scholar]
  5. Barrett-Connor E. Hypercholesterolemia predicts early death from coronary heart disease in elderly men but not women. The Rancho Bernardo Study. Ann Epidemiol. 1992 Jan-Mar;2(1-2):77–83. doi: 10.1016/1047-2797(92)90040-w. [DOI] [PubMed] [Google Scholar]
  6. Benfante R., Reed D. Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA. 1990 Jan 19;263(3):393–396. [PubMed] [Google Scholar]
  7. Berg K., Rø O. C. Lp(a) lipoprotein level and longevity. Ann Genet. 1991;34(3-4):264–269. [PubMed] [Google Scholar]
  8. Bogner U., Arntz H. R., Peters H., Schleusener H. Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified. Acta Endocrinol (Copenh) 1993 Mar;128(3):202–206. doi: 10.1530/acta.0.1280202. [DOI] [PubMed] [Google Scholar]
  9. Brown B. G., Zhao X. Q., Sacco D. E., Albers J. J. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 1993 Jun;87(6):1781–1791. doi: 10.1161/01.cir.87.6.1781. [DOI] [PubMed] [Google Scholar]
  10. Cosgrove D. M., Loop F. D., Lytle B. W., Gill C. C., Golding L. A., Gibson C., Stewart R. W., Taylor P. C., Goormastic M. Determinants of 10-year survival after primary myocardial revascularization. Ann Surg. 1985 Oct;202(4):480–490. doi: 10.1097/00000658-198510000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ettinger W. H., Wahl P. W., Kuller L. H., Bush T. L., Tracy R. P., Manolio T. A., Borhani N. O., Wong N. D., O'Leary D. H. Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group. Circulation. 1992 Sep;86(3):858–869. doi: 10.1161/01.cir.86.3.858. [DOI] [PubMed] [Google Scholar]
  12. Evans P., Gray D. P. Value of screening for secondary causes of hyperlipidaemia in general practice. BMJ. 1994 Aug 20;309(6953):509–510. doi: 10.1136/bmj.309.6953.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Florkowski C. M., Cramb R., Hughes E. A. The incidence of asymptomatic hypothyroidism in new referrals to a hospital lipid clinic. Ann Clin Biochem. 1992 Mar;29(Pt 2):237–238. doi: 10.1177/000456329202900225. [DOI] [PubMed] [Google Scholar]
  14. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  15. Forette B., Tortrat D., Wolmark Y. Cholesterol as risk factor for mortality in elderly women. Lancet. 1989 Apr 22;1(8643):868–870. doi: 10.1016/s0140-6736(89)92865-1. [DOI] [PubMed] [Google Scholar]
  16. Frishman W. H., Ooi W. L., Derman M. P., Eder H. A., Gidez L. I., Ben-Zeev D., Zimetbaum P., Heiman M., Aronson M. Serum lipids and lipoproteins in advanced age. Intraindividual changes. Ann Epidemiol. 1992 Jan-Mar;2(1-2):43–50. doi: 10.1016/1047-2797(92)90036-p. [DOI] [PubMed] [Google Scholar]
  17. Garber A. M., Littenberg B., Sox H. C., Jr, Wagner J. L., Gluck M. Costs and health consequences of cholesterol screening for asymptomatic older Americans. Arch Intern Med. 1991 Jun;151(6):1089–1095. [PubMed] [Google Scholar]
  18. Glueck C. J., Lang J., Tracy T., Speirs J. The common finding of covert hypothyroidism at initial clinical evaluation for hyperlipoproteinemia. Clin Chim Acta. 1991 Sep 14;201(1-2):113–122. doi: 10.1016/0009-8981(91)90032-8. [DOI] [PubMed] [Google Scholar]
  19. Glueck C. J., Levy R. I., Glueck H. I., Gralnick H. R., Greten H., Fredrickson D. S. Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance. Am J Med. 1969 Aug;47(2):318–324. doi: 10.1016/0002-9343(69)90158-2. [DOI] [PubMed] [Google Scholar]
  20. Gylling H., Strandberg T., Tilvis R., Miettinen T. A. Regulation of serum cholesterol level in middle-aged and elderly men. Relation of cholesterol absorption and synthesis to lipoprotein metabolism. Arterioscler Thromb. 1994 May;14(5):694–700. doi: 10.1161/01.atv.14.5.694. [DOI] [PubMed] [Google Scholar]
  21. Hazzard W. R. Dyslipoproteinemia in the elderly. Should it be treated? Clin Geriatr Med. 1992 Feb;8(1):89–102. [PubMed] [Google Scholar]
  22. Howard B. V. Lipoprotein metabolism in diabetes mellitus. J Lipid Res. 1987 Jun;28(6):613–628. [PubMed] [Google Scholar]
  23. Jackson R., Beaglehole R. Evidence-based management of dyslipidaemia. Lancet. 1995 Dec 2;346(8988):1440–1442. doi: 10.1016/s0140-6736(95)92466-3. [DOI] [PubMed] [Google Scholar]
  24. Jacobs D., Blackburn H., Higgins M., Reed D., Iso H., McMillan G., Neaton J., Nelson J., Potter J., Rifkind B. Report of the Conference on Low Blood Cholesterol: Mortality Associations. Circulation. 1992 Sep;86(3):1046–1060. doi: 10.1161/01.cir.86.3.1046. [DOI] [PubMed] [Google Scholar]
  25. Jagger C., Clarke M., Clarke S. J. Getting older--feeling younger: the changing health profile of the elderly. Int J Epidemiol. 1991 Mar;20(1):234–238. doi: 10.1093/ije/20.1.234. [DOI] [PubMed] [Google Scholar]
  26. Johnson W. D., Brenowitz J. B., Kayser K. L. Factors influencing long-term (10-year to 15-year) survival after a successful coronary artery bypass operation. Ann Thorac Surg. 1989 Jul;48(1):19–25. doi: 10.1016/0003-4975(89)90170-7. [DOI] [PubMed] [Google Scholar]
  27. Kario K., Matsuo T. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis. Atherosclerosis. 1993 Nov;103(2):131–138. doi: 10.1016/0021-9150(93)90256-t. [DOI] [PubMed] [Google Scholar]
  28. Kervinen K., Savolainen M. J., Salokannel J., Hynninen A., Heikkinen J., Ehnholm C., Koistinen M. J., Kesäniemi Y. A. Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians. Atherosclerosis. 1994 Jan;105(1):89–95. doi: 10.1016/0021-9150(94)90011-6. [DOI] [PubMed] [Google Scholar]
  29. Kihara S., Matsuzawa Y., Kubo M., Nozaki S., Funahashi T., Yamashita S., Sho N., Tarui S. Autoimmune hyperchylomicronemia. N Engl J Med. 1989 May 11;320(19):1255–1259. doi: 10.1056/NEJM198905113201906. [DOI] [PubMed] [Google Scholar]
  30. LaRosa J. C., Applegate W., Crouse J. R., 3rd, Hunninghake D. B., Grimm R., Knopp R., Eckfeldt J. H., Davis C. E., Gordon D. J. Cholesterol lowering in the elderly. Results of the Cholesterol Reduction in Seniors Program (CRISP) pilot study. Arch Intern Med. 1994 Mar 14;154(5):529–539. doi: 10.1001/archinte.154.5.529. [DOI] [PubMed] [Google Scholar]
  31. Mann J. I., Lewis B., Shepherd J., Winder A. F., Fenster S., Rose L., Morgan B. Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain. Br Med J (Clin Res Ed) 1988 Jun 18;296(6638):1702–1706. doi: 10.1136/bmj.296.6638.1702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. O'Kane M. J., Neely R. D., Trimble E. R., Nicholls D. P. The incidence of asymptomatic hypothyroidism in new referrals to a hospital lipid clinic. Ann Clin Biochem. 1991 Sep;28(Pt 5):509–511. doi: 10.1177/000456329102800515. [DOI] [PubMed] [Google Scholar]
  33. Pocock S. J., Seed P. T. Cholesterol in elderly women. Lancet. 1992 Jun 6;339(8806):1426–1426. doi: 10.1016/0140-6736(92)91254-6. [DOI] [PubMed] [Google Scholar]
  34. Roth M., Tym E., Mountjoy C. Q., Huppert F. A., Hendrie H., Verma S., Goddard R. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986 Dec;149:698–709. doi: 10.1192/bjp.149.6.698. [DOI] [PubMed] [Google Scholar]
  35. Series J. J., Biggart E. M., O'Reilly D. S., Packard C. J., Shepherd J. Thyroid dysfunction and hypercholesterolaemia in the general population of Glasgow, Scotland. Clin Chim Acta. 1988 Mar 15;172(2-3):217–221. doi: 10.1016/0009-8981(88)90326-9. [DOI] [PubMed] [Google Scholar]
  36. Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]
  37. Skartlien A. H., Lyberg-Beckmann S., Holme I., Hjermann I., Prydz H. Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma. Arteriosclerosis. 1989 Nov-Dec;9(6):798–801. doi: 10.1161/01.atv.9.6.798. [DOI] [PubMed] [Google Scholar]
  38. Tunbridge W. M., Evered D. C., Hall R., Appleton D., Brewis M., Clark F., Evans J. G., Young E., Bird T., Smith P. A. Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) 1977 Dec;7(6):495–508. doi: 10.1111/j.1365-2265.1977.tb01341.x. [DOI] [PubMed] [Google Scholar]
  39. Zimetbaum P., Frishman W. H., Ooi W. L., Derman M. P., Aronson M., Gidez L. I., Eder H. A. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study. Arterioscler Thromb. 1992 Apr;12(4):416–423. doi: 10.1161/01.atv.12.4.416. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES